THURSDAY, Nov. 19 (HealthDay News) — A spray touted as the first potential treatment for premature ejaculation has proved effective in a second study, according to the company that developed it.
PSD502 — which combines the drugs lidocaine and prilocaine — is sprayed on the head of the penis before intercourse.
The study of men in Canada, Poland and the United States found that those treated with the spray five minutes before intercourse were able to delay ejaculation up to five times longer than those who used a placebo. In addition, men who used the spray and their partners reported improved sexual satisfaction. Read More





WEDNESDAY, Nov. 18 (HealthDay News) —
MONDAY, Nov. 16 (HealthDay News) — Teen girls aged 15 to 19 accounted for the largest number (409,531) of the 1.5 million reported
MONDAY, Nov. 16 (HealthDay News) — New industry-funded research suggests that the
WEDNESDAY, Nov. 4 (HealthDay News) — A vaccine that targets
MONDAY, Nov. 2 (HealthDay News) — In 2002 and 2003, screening guidelines for the cervical cancer-detecting
WEDNESDAY, Oct. 28 (HealthDay News) — Women undergoing a second round of in-vitro fertilization should get one embryo instead of two, suggests new Swedish research that found the first approach is almost as successful as the second and greatly reduces the risk of multiple births.
TUESDAY, Oct. 27 (HealthDay News) — Traditional Pap tests and the newer liquid-based cytology are equally reliable in screening for cervical cancer, a new study has found.
FRIDAY, Oct. 23 (HealthDay News) — There have been reports that injections of the
THURSDAY, Oct. 22 (HealthDay News) — Doctors should prescribe oral phosphodiesterase type 5 (PDE-5) inhibitor drugs, such as Viagra, Cialis and Levitra, for men with